Celltrion Pharm, Inc. (KOSDAQ: 068760)

Celltrion Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	25,628	25,748	10,764	9,118	5,638	10,195
Short-Term Investments	9,000	4,000	2,568	-	315	315
Cash & Short-Term Investments	34,628	29,748	13,332	9,118	5,953	10,510
Cash Growth	66.52%	123.13%	46.22%	53.16%	-43.36%	0.89%
Accounts Receivable	154,954	140,466	138,776	132,728	123,466	80,708
Other Receivables	2,646	1,550	689.3	608.19	2,034	636.14
Receivables	157,600	142,016	139,466	133,336	125,587	81,761
Inventory	59,372	55,014	33,102	42,017	65,243	65,872
Prepaid Expenses	1,138	850.11	671.36	1,048	1,029	1,440
Other Current Assets	4,431	3,326	2,285	14,442	13,296	12,260
Total Current Assets	257,169	230,954	188,855	199,961	211,107	171,843
Property, Plant & Equipment	247,137	248,256	216,577	195,554	199,864	209,836
Long-Term Investments	932.59	932.59	2,223	1,582	1,333	1,333
Goodwill	32,912	32,912	32,912	32,912	32,912	32,912
Other Intangible Assets	2,149	2,049	2,247	2,106	1,910	2,161
Long-Term Accounts Receivable	-0	-0	0	0	-	-
Long-Term Deferred Tax Assets	16,981	17,609	15,655	18,072	16,319	15,989
Long-Term Deferred Charges	3,100	3,090	1,203	802.81	5,084	5,435
Other Long-Term Assets	12,518	12,272	11,308	1,455	1,426	2,189
Total Assets	572,899	548,075	470,980	452,444	470,269	442,081
Accounts Payable	33,172	21,613	6,810	12,376	13,169	12,765
Accrued Expenses	1,993	1,870	1,466	1,635	953.81	393.78
Short-Term Debt	121,423	121,000	108,960	98,853	89,249	29,732
Current Portion of Long-Term Debt	13,750	13,750	13,750	13,750	6,875	20,000
Current Portion of Leases	495.47	421.21	364.91	-	-	-
Current Income Taxes Payable	857.74	754.93	315.3	-	1.29	1,214
Other Current Liabilities	36,562	25,518	17,472	18,421	14,043	8,282
Total Current Liabilities	208,253	184,927	149,139	145,034	124,290	72,387
Long-Term Debt	55,437	57,264	38,603	34,375	48,125	89,000
Long-Term Leases	644.11	586.58	207.52	-	-	-
Long-Term Unearned Revenue	3,000	3,000	3,000	3,000	3,000	3,000
Other Long-Term Liabilities	2,810	1,736	-	-	964.34	764.34
Total Liabilities	270,145	247,514	190,949	182,409	176,646	165,375
Common Stock	18,263	17,905	17,045	17,033	16,670	15,828
Additional Paid-In Capital	250,922	250,908	250,460	297,800	296,991	295,426
Retained Earnings	38,521	31,566	11,168	-45,123	-20,910	-35,833
Treasury Stock	-7,572	-2,337	-1,233	-1,233	-202.72	-101.14
Comprensive Income & Other	2,620	2,520	2,592	1,558	1,075	1,386
Shareholders' Equity	302,754	300,561	280,031	270,035	293,624	276,706
Total Liabilities & Equity	572,899	548,075	470,980	452,444	470,269	442,081
Total Debt	191,750	193,022	161,885	146,978	144,249	138,732
Net Cash (Debt)	-157,123	-163,274	-148,554	-137,860	-138,296	-128,222
Net Cash Per Share	-3772.48	-3923.38	-3576.27	-3331.97	-3388.67	-3707.86
Filing Date Shares Outstanding	41.39	41.43	39.46	41.4	41.35	39.26
Total Common Shares Outstanding	41.39	41.43	41.43	41.4	41.35	39.26
Working Capital	48,916	46,027	39,717	54,926	86,816	99,455
Book Value Per Share	7314.07	7254.30	6759.02	6522.17	7101.76	7047.76
Tangible Book Value	267,692	265,599	244,872	235,017	258,801	241,632
Tangible Book Value Per Share	6467.03	6410.48	5910.39	5676.38	6259.51	6154.42
Land	18,926	18,926	18,926	18,926	18,926	18,926
Buildings	128,880	127,825	116,458	107,922	107,231	107,100
Machinery	159,482	141,878	113,521	112,786	110,019	108,665
Construction In Progress	12,491	28,820	26,070	4,164	208.3	-

Source: S&P Capital IQ. Standard template. Financial Sources.